How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation. View classification details, related manufacturers, 510(k) clearances, and recall records.
293 clearance records and 240 recall records in the covered releases, across 22 source company names and 1 product codes. Dated history runs from Aug 1, 1986 to Nov 4, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 1 | 0 |
| April 2026 | 1 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 3 |
| July 2026 | 0 | 1 |
| August 2026 | 0 | 2 |
| September 2026 | 1 | 0 |
| October 2026 | 1 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| LON · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation | 293 | 240 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM- CEFUROXIME GRAM NEGATIVEK033362 · LON | Becton, Dickinson & CO | 510(k) | Apr 9, 2004FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TRIMETHOPRIM-SULFAMETHOXAZOLE 0.5/9.5 - 16/304 UG/MLK033907 · LON | Becton, Dickinson & CO | 510(k) | Apr 9, 2004FDA decision date |
| MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH CEPHALOTHIN (0.5-32 UG/ML)K031601 · LON | Dade Behring, Inc. | 510(k) | Apr 2, 2004FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEMK040099 · LON | Becton, Dickinson & CO | 510(k) | Mar 19, 2004FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM -- AMPICILLIN -- GRAM POSITIVEK040106 · LON | Becton, Dickinson & CO | 510(k) | Mar 11, 2004FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFEPIME (GN) 0.5-65 UG/MLK032675 · LON | Becton, Dickinson & CO | 510(k) | Mar 1, 2004FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-LINEZOLID-GRAM POSITIVEK040006 · LON | Becton, Dickinson & CO | 510(k) | Feb 27, 2004FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - ERYTHROMYCIN 0.0625-8 UG/MLK033784 · LON | Becton, Dickinson & CO | 510(k) | Feb 3, 2004FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM FOR USE WITH THE ANTIMICROBIAL AGENT CHLORAMPHENICOL 1-32 UG/ML GRAM POSITIVEK033889 · LON | Becton, Dickinson & CO | 510(k) | Feb 3, 2004FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TICARCILLIN/CLAVULANATE-GRAM NEGATIVEK033557 · LON | Becton, Dickinson & CO | 510(k) | Jan 14, 2004FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFTAZIDIME 0.5-64 UG/ML-GRAM-NEGATIVE ID/AST OR AST ONLY PHOENIX PANELSK033560 · LON | Becton, Dickinson & CO | 510(k) | Jan 14, 2004FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - AZTREONAM 0.5-64 UG/ML-GRAM-NEGATIVE ID/AST OR AST ONLY PHOENIX PANELSK033558 · LON | Becton, Dickinson & CO | 510(k) | Dec 19, 2003FDA decision date |
| MYCOPLASMA IGGK033064 · LON | Trinity Biotech USA | 510(k) | Nov 26, 2003FDA decision date |
| MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH AMPICILLIN (0.25-128 UG/ML)K033482 · LON | Dade Behring, Inc. | 510(k) | Nov 26, 2003FDA decision date |
| VITEK 2 GRAM NEGATIVE MOXIFLOXACINK032861 · LON | bioMerieux, Inc. | 510(k) | Nov 12, 2003FDA decision date |
| VITEK 2 GRAM NEGATIVE GATIFLOXACINK032788 · LON | bioMerieux, Inc. | 510(k) | Nov 4, 2003FDA decision date |
| VITEK GRAM NEGATIVE GATIFLOXACINK032711 · LON | bioMerieux, Inc. | 510(k) | Oct 31, 2003FDA decision date |
| VITEK 2 GRAM POSITIVE QUINUPRISTIN/DALFOPRISTINK032738 · LON | bioMerieux, Inc. | 510(k) | Oct 31, 2003FDA decision date |
| VITEK 2 GRAM POSITIVE LINEZOLIDK032766 · LON | bioMerieux, Inc. | 510(k) | Oct 31, 2003FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFTRIAXONE 0.5-64 UG/MLK032655 · LON | Becton, Dickinson & CO | 510(k) | Oct 6, 2003FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-IMIPENEM 1-16 UG/ML GRAM-NEGATIVE ID/AST OR AST ONLY PHOENIX PANELSK032275 · LON | Becton, Dickinson & CO | 510(k) | Sep 29, 2003FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM,-AMPICILLIN 0.5.-32 UG/MLK032299 · LON | Becton, Dickinson & CO | 510(k) | Sep 22, 2003FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CEFOXITIN-GRAM NEGATIVEK032567 · LON | Becton, Dickinson & CO | 510(k) | Sep 17, 2003FDA decision date |
| BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM CEFOTAXIME 0.5-64 UG/MLK032153 · LON | Bd Diagnostic Systems | 510(k) | Sep 11, 2003FDA decision date |
| VITEK 2 GRAM POSITIVE MOXIFLOXACINK032399 · LON | bioMerieux, Inc. | 510(k) | Sep 10, 2003FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.